Philip Pratten joins PCI Pharma Services as Senior Director at its Tredegar, UK Site
October 3, 2016 – Manufacturing and Packing –
Philadelphia, USA – October 3, 2016. Leading pharmaceutical outsourcing provider PCI Pharma Services has appointed Philip Pratten as Senior Director in its new business development team, supporting PCI at its Tredegar site in Wales, UK, recognized as a center of excellence for manufacturing.
Philip Pratten joins PCI to help drive its continued commercial growth and success. He brings to PCI over 30 yearsí experience in the life sciences and pharmaceutical industry, firstly in blue chip pharma, followed by more than 18 years in contract pharma services. He has also held various business development and sales leadership roles in drug delivery, biologics and traditional CMC with a proven track record of development, commercial and technology deals secured.
Commenting on his appointment, Robert Jones, International Business Development Director at PCI, said: “We are pleased to welcome Philip to our new business development team. With over 30 years in the industry, he brings with him a great deal of experience in business development across the pharma sector, and we hope his knowledge will help support our continued expansion across Europe and the US.”
Philip is looking forward to joining the team at PCI, he said: “I am thrilled to be joining PCI Pharma Services at an exciting time as the business continues to expand, and Iím particularly excited to lead the business development team to help drive further commercial growth for PCI.”
To find out more about PCI, please visit www.pciservices.com.
About PCI
The global healthcare industry trusts PCI for the drug development solutions that increase their productsí speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle ó from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patientsí lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.
Join PCI Pharma Servicesí experts at this yearís CPhI Worldwide event (Barcelona, October 4-6, 2016). PCI have secured two slots at the ICSE Exhibitor Showcase, the presentations will focus on the safe handling and manufacture of Potent Molecules (October 4 at 13:30-13:55) and Serialization strategy and implementation (October 5 at 12:00-12:25). Visit the PCI Pharma Services stand at 3B16.
Contact
Chantel Richman / Carrie Lowe at Remarkable Content
chantel.richman@remarkablegroup.co.uk / carrie.lowe@remarkablegroup.co.uk
T: +44 (0) 1962 893 853 / 913
